SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review

AIM OF THE STUDY: To evaluate the efficacy of sodium/glucose cotransporter-2 inhibitors (SGLT2i) in improving hepatic fibrosis and steatosis of non-alcoholic fatty liver disease (NAFLD) patients with type 2 diabetes mellitus (T2DM). MATERIAL AND METHODS: We searched CENTRAL, MEDLINE, and EMBASE and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Exp Hepatol
Main Authors: Dwinata, Michael, Putera, David Dwi, Hasan, Irsan, Raharjo, Monica
Formato: Artigo
Idioma:Inglês
Publicado em: Termedia Publishing House 2020
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7816633/
https://ncbi.nlm.nih.gov/pubmed/33511282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceh.2020.102173
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados